Folacin.

Methionine synthase hands the methyl group from 5-methyltetrahydrofolate to homocysteine using methylcobalamin as its carrier. Without enough B12 the folate pool stalls in the methyl form and cannot re-enter the one-carbon cycle.

B6 as pyridoxal-5-phosphate runs the transsulfuration route that moves homocysteine on to cysteine, while folate runs the remethylation route. Supplying both covers the two exits homocysteine has.

Methylenetetrahydrofolate reductase carries FAD, which riboflavin supplies, so it is the enzyme that converts folate into its circulating methyl form. Low riboflavin lowers the output of that step, most visibly in people carrying the thermolabile MTHFR variant.

Folacin has to pass through dihydrofolate reductase and MTHFR before it becomes 5-methyltetrahydrofolate, the form the blood carries. The methylated form skips those conversion steps, which matters where reductase capacity is limited.

Folinic acid is already a reduced formyl folate, so it enters the pool past the dihydrofolate reductase step that folacin depends on. Both feed the same tetrahydrofolate carrier pool used for purine and thymidylate assembly.

Choline oxidises to betaine, which donates a methyl group to homocysteine through a route parallel to the folate one. When folate intake runs low the body pulls harder on choline, and the same is true in the other direction.

Betaine-homocysteine methyltransferase remethylates homocysteine using betaine instead of 5-methyltetrahydrofolate. It gives the same reaction a second, folate-independent supply line, mainly in liver and kidney.

The glycine cleavage system loads a one-carbon unit onto tetrahydrofolate, which is one of the main ways the folate pool gets charged. Serine and glycine interconversion is the entry point for most one-carbon units folate carries.

Serine hydroxymethyltransferase transfers a carbon from serine onto tetrahydrofolate, producing glycine and the methylene folate that feeds MTHFR. This is the quantitatively largest source of one-carbon units for folate.

The methyl group folate delivers to homocysteine makes methionine, which is then adenosylated to SAM-e, the cell's working methyl donor. SAM-e levels also feed back on MTHFR, so the two sit on one loop.

Folate-dependent remethylation of homocysteine is one of the two ways the body regenerates methionine. Dietary methionine loading raises homocysteine flux and so raises demand on the folate pool.

Reduced folates oxidise readily in solution and in the stomach, and ascorbate keeps them in the reduced state. This is why folate assays and many formulations pair the two.

Dihydrofolate reductase uses NADPH to reduce folacin to its active tetrahydro form, and NADPH is built on the nicotinamide nucleotide pool. Poor niacin status narrows the reducing power available to that step.

Folate polyglutamates are cleaved before absorption by a zinc-dependent intestinal conjugase, and folic acid can form a complex with zinc in the gut lumen that lowers the amount of zinc taken up. The interaction is dose-dependent and shows mainly at high supplemental folic acid alongside marginal zinc intake.

Methylenetetrahydrofolate reductase reduces its substrate using NADPH, and the nicotinamide ring of NADPH traces back to niacin. Folate can be present in full while the reduction step is limited by reducing power. The two occupy different positions in the same cycle.

Serine hydroxymethyltransferase moves a one-carbon unit from serine onto tetrahydrofolate, and that enzyme needs pyridoxal-5-phosphate. Without it the folate pool is harder to load with the carbon units it exists to carry. This is textbook cofactor dependence.

Folylpolyglutamate synthase attaches the glutamate tail that keeps folate inside the cell, and it is an ATP-dependent enzyme working with magnesium as the counter-ion. Magnesium status therefore sits underneath folate retention rather than beside it. The relationship is mechanistic and has not been tested as a supplement pair.

Making creatine in the body consumes a large share of the available S-adenosylmethionine methyl groups, and those methyl groups are regenerated through the folate cycle. Taking creatine reduces the endogenous synthesis demand and so the methyl draw. The direction is plausible and measured mainly in markers.

Folate supplies the one-carbon units for thymidylate synthesis needed for cell division, while iron is built into the haem of the red cell. They support the same process from two unrelated directions, which is why prenatal formulas carry both. Neither substitutes for the other.

EGCG has been described as an inhibitor of dihydrofolate reductase in laboratory systems, the same enzyme that reduces folic acid to its usable tetrahydro form. Whether meaningful inhibition occurs at ordinary dietary intakes in people is not settled. Read it as mechanistic rather than clinical.

Inositol and folate are both studied in the context of normal early neural development and appear together in preconception formulas. The pairing has more formulation history than head-to-head measurement. The rationale is mechanistic overlap, not a joint trial.